The number of Americans applying for unemployment benefits rose last week to 778,000, evidence that the U.S. economy and job market remain under strain as coronavirus cases surge and colder weather heighten the risks.
AstraZeneca is the third major drug company to report late-stage results for a potential COVID-19 vaccine as the world anxiously waits for scientific breakthroughs that will bring an end to a pandemic that has wrought economic devastation and resulted in nearly 1.4 million confirmed deaths.
With El Paso hospitals and ICUs over capacity since last month due to one of the worst COVID-19 surges in the country, three Air Force medical teams have spent the past two weeks deployed to aid in the fight.
U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.
Efforts to require lawmakers and staff to wear masks have received a cool reception even in statehouses that have seen outbreaks of the virus or where Republican governors have issued statewide mandates.
The surging coronavirus is taking an increasingly dire toll across the U.S. just as a vaccine appears at hand, with the country now averaging over 1,300 COVID-19 deaths per day — the highest since the calamitous spring in and around New York City.
The announcement from Pfizer and its German partner BioNTech, just a week after they revealed the first promising preliminary results, comes as the team is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.
The announcement, just a week after Pfizer first revealed promising preliminary results, comes as the company is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.